Fort Collins, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the antacid market size was evaluated at USD 7.4 Billion in 2022 and is expected to reach USD 11.6 Billion by 2032 at a CAGR of 4.8%.
Antacids contain salts of magnesium, calcium, aluminum, and sodium as active ingredients and are used to cure stomach-related problems like indigestion, acid reflux, heartburn, and upset stomach.
Gut and intestine-related problems have become a common thing nowadays. A sedentary lifestyle, poor sleep cycle, and consumption of unhealthy and junk food are leading to the prevalence of various gut-related diseases like gastroesophageal reflux disease (GERD) and duodenal ulcers are driving the demand for antacids. For instance, several studies have demonstrated that the prevalence of gastroesophageal reflux disease (GERD) ranges from around 10% to 48% in Western countries and is increasing steadily, a major driver for the antacid market.
Additionally, as antacids are self-medicated and over-to-counter (OTC) drugs that are easily available in different flavours and formulations like liquid syrups, tablets, and chewable gummies, enabling consumers to choose any antacid according to their preference. For instance, a study by medical students on self-medicated drugs revealed that antacids were the second most commonly used drugs with a high frequency. The demand for antacids increased largely during the COVID-19 pandemic as gastrointestinal symptoms like heartburn and acidity were more prevalent. This led to a huge increase in market share for antacids.
Request Sample Report:
https://datahorizzonresearch.com/request-sample-pdf/antacids-market-2263
Segmentation Overview:
The global antacids market has been segmented into dosage, distribution channel, and region. Retail pharmacy holds the highest market share due to easy accessibility and convenience. The liquid syrup segment is expected to be the fastest-growing segment during the forecast period. Liquid antacids are available in many flavors and are preferred by children and old people as they are more palatable.
North America held the highest market share in 2022 due to the presence of well-developed health infrastructure, easy medication availability, and increasing incidences of heartburn and gastritis. Furthermore, incidences of GERD, gastritis, peptic ulcers, and duodenal ulcers are prevailing in the US and neighboring countries of North America, thus creating more demand for antacids.
Buy This Research Report:
https://datahorizzonresearch.com/checkout-page/antacids-market-2263
Antacids Market Report Highlights:
- The global antacids market growth is anticipated at a CAGR of 4.8% by 2032.
- Factors such as the broader availability of antacids in various forms in the retail markets owing to consumer preference.
- Tablets are the largest growing segments in the dosage form attributed to their easy availability in medical stores.
- In terms of distribution channel, retail pharmacies have maintained a high competitive edge in 2022.
- Online pharmacies dominate the market because of the online discounts and coupons.
- Some prominent players in the Antacids market report include Bayer AG, Abbott Laboratories, Johnson & Johnson, Sanofi, Procter & Gamble, Novartis Consumer Health, Pfizer Inc, Dr. Reddy’s Laboratories Ltd, Sun Pharmaceuticals Ltd, and Reckitt Benckiser Group plc.
Industry Trends and Insights:
- Recently, Sun Pharmaceutical Ltd developed an ayurvedic digestive care product, Pepmelt. It is an innovative product launched in a mouth-melt granule form of herbal ingredients.
- GlaxoSmithKline plc acquired a stake in Novartis to strengthen the company’s healthcare business globally.
Looking Exclusively For Region/Country Specific Report?
https://datahorizzonresearch.com/ask-for-customization/antacids-market-2263
OR
Ask For Discount
https://datahorizzonresearch.com/ask-for-discount/antacids-market-2263
Antacids Market Segmentation:
- By Dosage Form: Liquid syrups, chewable tablets.
- By Distribution Channel: Retail pharmacy, hospital pharmacy, online pharmacy.
- By Region: North America, Latin America, Europe, Asia Pacific, the Middle East and Africa.
About DataHorizzon Research:
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
Contact:
Mail: sales@datahorizzonresearch.com
Ph: +1-970-672-0390
Website: https://datahorizzonresearch.com/
Follow Us: LinkedIn
Recent Publications
Liquid Biopsy Market 2023 to 2032
Hearing Aids Market 2023 to 2032
Exoskeleton Market 2023 to 2032
Active Pharmaceutical Ingredients Market 2023 to 2032
Gait Biometrics Market 2023 to 2032
